Shinallerg Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per mL Tetrahydrozoline HCl 0.4 mg, antazoline HCl 0.5 mg

Indications/Uses

Non-infectious irritative conjunctivitis, allergic-inflammatory conjunctival affections, hay fever & conjunctivitis vernalis.

Click to view Shinallerg detailed prescribing information

Dosage/Direction for Use

Apply 1 drop every 3 hr during acute phase. Maintenance therapy Apply 1 drop bd-tds. Childn 1-2 drops daily.

Click to view Shinallerg detailed prescribing information

Overdosage

View Shinallerg overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Concomitant use w/ MAOIs.

Click to view Shinallerg detailed prescribing information

Special Precautions

Not to be used in patients w/ dry eyes. Patients w/ diabetes, HTN, hyperthyroidism & elevated thyroid hormone conc, arrhythmias or tachycardia & phaeochromocytomas; rhinitis sicca. Patients at risk of or w/ angle-closure glaucoma. Remove contact lens prior to application & wait 15 min before reinsertion. May affect ability to drive or operate machines. Pregnancy & lactation. Elderly w/ CV disease.

Click to view Shinallerg detailed prescribing information

Use In Pregnancy & Lactation

Click to view Shinallerg detailed prescribing information

Adverse Reactions

Burning & stinging sensation in eyes, iris exfoliation, mydriasis, blurred vision, acute, chronic & acute follicular conjunctivitis, dry eyes, conjunctival congestion, ocular hyperaemia, angle-closure glaucoma; headache, somnolence, drowsiness, dizziness, tremor & central excitation; angina pectoris, HTN & tachycardia; sweating.

Drug Interactions

Hypertensive crisis w/ MAOIs. Enhanced sedating effects of CNS depressants eg, alcohol, hypnotics, opioid analgesics, anxiolytic sedatives & antipsychotics. Additive anti-muscarinic action w/ other antimuscarinic drugs eg, atropine & some antidepressants (both tricyclics & MAOIs). HTN, severe headache, seizures & psychosis w/ bromocriptine. Possible severe HTN w/ digitalis, β-adrenergic blockers, guanethidine, reserpine, methyldopa or antihypertensive agents. Provoked or worsened ventricular arrhythmias w/ cyclopropane & halogenated anesth agents eg, chloroform, halothane, enflurane or isoflurane.

Click to view Shinallerg detailed prescribing information

Storage

View Shinallerg storage conditions for details to ensure optimal shelf-life.

Description

View Shinallerg description for details of the chemical structure and excipients (inactive components).

Action

View Shinallerg mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories

ATC Classification

S01GA52 - tetryzoline, combinations ; Belongs to the class of sympathomimetics used as ophthalmologic decongestants.

Regulatory Classification

Presentation/Packing

Form

Shinallerg eye drops

Packing/Price

5 mL x 10 × 1's;5 mL x 12 × 1's;5 mL x 20 × 1's;5 mL x 24 × 1's

Shinallerg

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries